During the past decade, St. Istvan and St. Laszlo Hospital of Budapest conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Istvan and St. Laszlo Hospital of Budapest" #1 sponsor was "AOP Orphan Pharmaceuticals AG" with 3 trials, followed by "ANRS, Emerging Infectious Diseases" with 1 trials sponsored, "Amgen" with 1 trials sponsored, "CTI BioPharma" with 1 trials sponsored and "European Society for Blood and Marrow Transplantation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Istvan and St. Laszlo Hospital of Budapest" #1 collaborator was "NEAT - European AIDS Treatment Network" with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator, "PharmaEssentia Corporation (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (for the U.S.)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "St. Istvan and St. Laszlo Hospital of Budapest" are "Polycythemia Vera" (3 trials), "Acute Myeloid Leukemia" (1 trials), "DLBCL Transformed From Indolent Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Follicular Grade 3 Lymphoma" (1 trials). Many other conditions were trialed in "St. Istvan and St. Laszlo Hospital of Budapest" in a lesser frequency.

Most popular intervention types in "St. Istvan and St. Laszlo Hospital of Budapest" are "Drug" (9 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Best available therapy (BAT)" (1 trials), "Busulfan" (1 trials), "Carfilzomib" (1 trials), "DermaVir" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Istvan and St. Laszlo Hospital of Budapest" are 11 trials for "All" genders.

Currently, there are NaN active trials in "St. Istvan and St. Laszlo Hospital of Budapest". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in St. Istvan and St. Laszlo Hospital of Budapest, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Istvan and St. Laszlo Hospital of Budapest, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".